Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.
Summer 2022

State of the States

A roundup of regulatory activity around the country
Summer 2022

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Three More States Introduce Psychedelics Bills, While FDA Sets MDMA Decision Date

Connecticut, Missouri, and New Hampshire join 10 other states considering psychedelics bills.
Mar 2024

Medical Issues Panel at IAIABC Forum & The Fear of Reinjury in Workers’ Comp

Amanda Waltemath, Director of Clinical Services joins a panel discussion on April 10th, and Tate Rice, Director of Product Management speaks to Risk & Insurance.
Mar 2024

FDA Evaluates Report of Suicidal Thoughts with GLP-1 Receptor Agonist

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.
Feb 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020
1 12 13 14 15 16 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle